Cairo - Mubasher: The consolidated financial statements of Minapharm Pharmaceuticals showed an increase in profits for the first quarter of 2017 by 6.22% year-on-year.
The company said in a statement to the Egyptian Exchange (EGX) on Tuesday that profits totalled EGP 58.8 million during the three-month period that ended 31 March 2017, compared to EGP 55.37 million in the same period in 2016.
Sales grew 58.21% in Q1-17 to EGP 421.7 million up from EGP 155.18 million in the same quarter of last year.
During the same period, independent profits reached EGP 7.72 million compared to EGP 29.14 million in Q1-16.
